Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA?

Kidney International

Volumn 69, Issue 8, 2006, Pages 1455-1458

  Nair, R ^a,b   Walker, P D ^a  

^a Nephropathology Associates   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Adult; FSGS; Glomerulonephritis; IgA nephropathy; USA

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; CAUCASIAN; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; INCIDENCE; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; PRIORITY JOURNAL; RARE DISEASE; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOPSY; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HISPANIC AMERICANS; HUMANS; INCIDENCE; MALE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 33646125198     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000292     Document Type: Article

References (34)

1. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int 1994; 46: 1223-1241.
2. Haas M, Spargo B, Coventry S. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study. Am J Kidney Dis 1995; 26: 740-750.
3. Kitiyakara C, Eggers P, Kopp J. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 2004; 44: 815-825.
4. Korbet S, Genchi R, Borok R et al. The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis 1996; 27: 647-651.
5. Dragovic D, Rosenstock J, Wahl S et al. Increasing incidence of focal segmental glomerulosclerosis and an examination of demographic patterns. Clin Nephrol 2005; 63: 1-7.
6. Pontier P, Patel T. Racial differences in the prevalence and presentation of glomerular disease in adults. Clin Nephrol 1994; 42: 79-84.
7. Braden G, Mulhern J, O'Shea M et al. Changing incidence of glomerular diseases in adults. Am J Kidney Dis 2000; 35: 878-883.
8. Research Group on progressive chronic renal disease. Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in1850 biopsied cases. Nephron 1999; 82: 205-213.
9. Ballardie FW, O'Donnaghue DJ, Peehally J. Increasing frequency of adult IgA nephropathy in the UK? Lancet 1987; 2: 1205.
10. Briganti E, Dowling J, Finlay M et al. The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant 2001; 16: 1364-1367.
11. Floege J, Grone H. IgA nephropathy: frequent, but rarely diagnosed. Internist (Berlin) 2003; 44: 1131-1139.
12. Jennette J, Wall S, Wilkman A. Low incidence of IgA nephropathy in blacks. Kidney Int 1985; 28: 944-950.
13. Li L, Liu Z. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13, 519 renal biopsies. Kidney Int 2004; 66: 920-923.
14. Pettersson E, von Bonsdorff M, Tornroth T et al. Nephritis among young Finnish men. Clin Nephrol 1984; 22: 217-222.
15. Rivera F, Lopez-Gomez J, Perez-Garcia R. Frequency of renal pathology in Spain, 1994-1999. Nephrol Dial Transplant 2002; 17: 1594-1602.
16. Schena F. Survey of Italian Registry of renal biopsies. Frequency of renal diseases for 7 consecutive years. Nephrol Dial Transplant 1997; 12: 418-426.
17. Seedat Y, Nathoo B, Parag K et al. IgA nephropathy in blacks and Indians of Natal. Nephron 1988; 50: 137-141.
18. Simon P, Ramee M, Boulahrouz R et al. Epidemiologic data of primary glomerular diseases in western France. Kidney Int 2004; 66: 905-908.
19. Sinniah R, Javier AR, Ku G. The pathology of mesangial IgA nephritis with clinical correlation. Histopathology 1981; 5: 469-490.
20. Stratta P, Segoloni G, Canavese C et al. Incidence of biopsy-proven primary glomerulonephritis in an Italian province. Am J Kidney Dis 1996; 27: 631-639.
21. Tiebosch A, Wolters J, Frederik P et al. Epidemiology of idiopathic glomerular disease: a prospective study. Kidney Int 1987; 32: 112-116.
22. Tojo S, Narita M, Koyama A. Natural history and treatment of IgA nephropathy in Japan. J Nephrol ROC 1987; 1: 305-318.
23. Woo K, Chiang G, Pall A et al. The changing pattern of glomerulonephritis in Singapore over the past two decades. Clin Nephrol 1999; 52: 96-102.
24. Berger J, Yaneva H, Crosnier J. Mesangial IgA glomerulonephritis: a frequent cause of terminal renal failure. Nouv Presse Med 1980; 9: 219-221.
25. US Renal Data System. USRDS 2004 Annual Data Report. Atlas of End-Stage Renal Disease in the United States, National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2004.
26. Wyatt R, Julian B, Baehler R et al. Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994. Central Kentucky Region of the Southeastern United States IgA Nephropathy DATABANK Project. J Am Soc Nephrol 1998; 9: 853-858.
27. US Census Bureau. Table 4. Annual estimates of the population by race alone and Hispanic or Latino origin for the United States - July 1 2004 (SC-EST2004-04). Available at www.census.gov. (Accessed 10/22/05).
28. Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988; 12: 340-347.
29. Geddes C, Rauta V, Gronhagen-Riska C et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 2003; 18: 1541-1548.
30. Jennette J. The immunohistology of IgA nephropathy. Am J Kidney Dis 1988; 12: 348-352.
31. Cameron J. Focal segmental glomerulosclerosis in adults. Nephrol Dial Transplant 2003; 18(Suppl 6): Svi45-Svi51.
32. Radford Jr MG, Donadio Jr JV, Bergstrahl EJ et al. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997; 8: 199-207.
33. Harmankaya O, Ozturk Y, Basturk T et al. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria. Int Urol Nephrol 2002; 33: 167-171.
34. Ibels L, Gyory A, Caterson R et al. Recognition and management of IgA nephropathy. Drugs 1998; 55: 73-83.